Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,556,667
-
Share change
-
+140,589
-
Total reported value
-
$33,339,856
-
Price per share
-
$21.42
-
Number of holders
-
39
-
Value change
-
+$2,150,828
-
Number of buys
-
20
-
Number of sells
-
23
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q1 2022
As of 31 Mar 2022,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,556,667 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Ovata Capital Management Ltd, ACADIAN ASSET MANAGEMENT LLC, Apis Capital Advisors, LLC, DIMENSIONAL FUND ADVISORS LP, TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.